ClinicalTrials.Veeva

Menu

EMA Baseline Screening System for Therapists Who Treat Youths With Depressive Symptoms

V

Vania Martínez-Nahuel

Status

Terminated

Conditions

Depressive Symptoms

Treatments

Behavioral: EMA prompting for patients
Behavioral: PDF Reports for therapists

Study type

Interventional

Funder types

Other

Identifiers

NCT04830527
030-2020

Details and patient eligibility

About

Youth depression is a matter of concern worldwide. It affects an important part of the young population around the world and its consequences both physically and mentally make this issue an important research field for psychologists and other health related professionals (Zuckerbrot, Cheung, Jensen, Stein & Laraque, 2018). Two of the biggest challenges that clinicians and researchers face when dealing with youth depression are adherence and the establishment of a therapeutic alliance (TA; Nock & Ferriter, 2005). While several treatments are available to relief depressive symptomatology in youths, a significant number do not access them for a variety of reasons (DiMatteo, Lepper & Corgan, 2000). In the last decades, substantial research has been conducted on how youths and the general population perceive therapy, and different methods have been developed to assess clients and therapists in order to improve outcomes and other aspects of the psychotherapy process, such as feedback tools and real-time measurements like Ecological Momentary Assessment (EMA) (Shiffman, et al., 2008). With the aid of Information Communication Technologies (ICTs) and eMental Health strategies, feedback and assessment tools can be presented in a friendly manner, providing a novel way to possibly improving adherence rates and TA scores. This study aims to develop and test the effectiveness of an Ecological Momentary Assessment mobile application to improve initial adherence and TA in psychotherapy for youths with depression.

The hypotheses for this trial are:

  1. Applying an EMA baseline screening application one week before the beginning of treatment for youth depression will significantly improve the TA.
  2. Applying an EMA baseline screening application one week before the beginning of treatment for youth depression will significantly improve initial adherence.

Enrollment

60 patients

Sex

All

Ages

18 to 24 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria for Patients:

  • Owning a mobile phone with permanent access to the internet,
  • Scoring from eleven to nineteen points in the PHQ-9 questionnaire.
  • Having completed the eighth grade of basic education.

Exclusion Criteria for Patients:

  • Being diagnosed with Depression with psychotic symptoms,
  • Having a depressive episode as part of a bipolar disorder diagnosis
  • Having suicidal thoughts and/or behaviour as measured by the PHQ-9 and evaluated by the physician.
  • Alcohol and/or substance abuse.

Inclusion Criteria for Therapists:

  • Having 1 or more years of clinical experience.

Exclusion Criteria for Therapists:

  • Having less than 1 year of clinical experience.
  • Having participated in the design of PDF reports.

Trial design

Primary purpose

Screening

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

60 participants in 2 patient groups

Intervention group
Experimental group
Description:
Patients in experimental group will receive EMA prompts. Therapists in this group will receive a summarized PDF report before the beginning of the first psychotherapy session. The report will include graphic summarized data from the EMA prompts.
Treatment:
Behavioral: PDF Reports for therapists
Behavioral: EMA prompting for patients
Control group
Active Comparator group
Description:
Patients in control group will receive the EMA prompts in the same manner as patients in the experimental group. Therapists in this group will not receive the PDF reports, and instead will get raw scores from a screening evaluation conducted with patients in the recruitment phase of the study.
Treatment:
Behavioral: EMA prompting for patients

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems